JP2024520788A5 - - Google Patents
Info
- Publication number
- JP2024520788A5 JP2024520788A5 JP2023575713A JP2023575713A JP2024520788A5 JP 2024520788 A5 JP2024520788 A5 JP 2024520788A5 JP 2023575713 A JP2023575713 A JP 2023575713A JP 2023575713 A JP2023575713 A JP 2023575713A JP 2024520788 A5 JP2024520788 A5 JP 2024520788A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- aqueous solution
- subject
- bumetanide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208863P | 2021-06-09 | 2021-06-09 | |
| US63/208,863 | 2021-06-09 | ||
| PCT/US2022/032862 WO2022261344A1 (en) | 2021-06-09 | 2022-06-09 | Subcutaneous formulation and methods for treating edema refractory to oral diuretics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520788A JP2024520788A (ja) | 2024-05-24 |
| JP2024520788A5 true JP2024520788A5 (cg-RX-API-DMAC10.html) | 2025-06-16 |
Family
ID=84425561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575713A Pending JP2024520788A (ja) | 2021-06-09 | 2022-06-09 | 経口利尿薬に不応性の浮腫を処置するための皮下製剤及び方法 |
Country Status (10)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3160278A1 (en) | 2019-12-04 | 2021-06-10 | Balasingam Radhakrishnan | Methods and compositions for treating edema refractory to oral diuretics |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040105818A1 (en) * | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
| WO2007149283A2 (en) * | 2006-06-16 | 2007-12-27 | Novacardia, Inc. | Use of kw-3902 for achieving diuresis in patients with congestive heart failure and acute fluid overload |
| EP2086329B1 (en) * | 2006-10-26 | 2014-07-23 | The Arizona Board of Regents on behalf of the University of Arizona | Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| US20140128469A1 (en) * | 2011-05-10 | 2014-05-08 | Concert Pharmaceuticals Inc. | Deuterated n-butyl bumetanide |
| CN105431145B (zh) * | 2013-04-05 | 2019-12-10 | Sc医药品有限公司 | 用于呋塞米的皮下施用的药物制剂 |
| WO2019193161A1 (en) * | 2018-04-06 | 2019-10-10 | Universität Wien | Bumetanide derivatives for the therapy of stroke and other neurological diseases/disorders involving nkccs |
| CA3160278A1 (en) * | 2019-12-04 | 2021-06-10 | Balasingam Radhakrishnan | Methods and compositions for treating edema refractory to oral diuretics |
-
2022
- 2022-06-09 JP JP2023575713A patent/JP2024520788A/ja active Pending
- 2022-06-09 US US18/568,440 patent/US20240285566A1/en active Pending
- 2022-06-09 AU AU2022289724A patent/AU2022289724A1/en active Pending
- 2022-06-09 KR KR1020247000323A patent/KR20240042402A/ko active Pending
- 2022-06-09 WO PCT/US2022/032862 patent/WO2022261344A1/en not_active Ceased
- 2022-06-09 CN CN202280053609.8A patent/CN117915905A/zh active Pending
- 2022-06-09 CA CA3221710A patent/CA3221710A1/en active Pending
- 2022-06-09 EP EP22821041.5A patent/EP4351554A4/en active Pending
- 2022-06-09 BR BR112023025880A patent/BR112023025880A2/pt not_active Application Discontinuation
- 2022-06-09 IL IL309160A patent/IL309160A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230112834A1 (en) | Parenteral formulations of treprostinil | |
| KR950013452B1 (ko) | 세포 및 조직 수복제 | |
| JP2023505189A5 (cg-RX-API-DMAC10.html) | ||
| EP1696932B1 (en) | Use of treprostinil to improve kidney functions | |
| US7879909B2 (en) | Use of Treprostinil to treat neuropathic diabetic foot ulcers | |
| JP2023002662A5 (cg-RX-API-DMAC10.html) | ||
| JP2023088944A5 (cg-RX-API-DMAC10.html) | ||
| JPH013193A (ja) | 細胞、組織修復剤 | |
| RU2013108857A (ru) | Соединения для лечения/профилактики воспалительных глазных заболевний | |
| RU2488393C2 (ru) | Жидкие композиции, включающие валсартан | |
| JP2711759B2 (ja) | 止瀉剤組成物 | |
| Ashchi et al. | Cardiac complication from use of cocaine and phenylephrine in nasal septoplasty | |
| US4789660A (en) | Insulin administration using methyl and propyl paraben | |
| Bergeron et al. | Myocardial infarction, severe reversible ischemia, and shock following excess thyroid administration in a woman with normal coronary arteries | |
| JP2590156B2 (ja) | 経口投与用医薬組成物 | |
| EA006015B1 (ru) | Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку | |
| JP2024532957A5 (cg-RX-API-DMAC10.html) | ||
| JP2023520703A5 (cg-RX-API-DMAC10.html) | ||
| ES2252751T3 (es) | Medicamento para el corazon pulmonar. | |
| Kulkarni et al. | Torsade de pointes and long QT syndrome following major blood transfusion | |
| Lunder et al. | SGLT-2 inhibitors: a novelty in the treatment of type 2 diabetes | |
| JPS5846023A (ja) | ヒトプロインシユリン製剤 | |
| RU2827071C1 (ru) | Средство для лечения дегенеративных процессов опорно-двигательного аппарата | |
| JP6935930B2 (ja) | 生薬成分を含む肺高血圧症の予防又は治療剤 | |
| JP2751464B2 (ja) | 経鼻投与製剤 |